Position paper 6 Dec 2023

Industry perspectives on implementation of Quality Overall Summary-Product Dossier (QOS-PD) and Quality Information Summary (QIS) for innovative medicinal products

In view of a growing complexity of product lifecycle management, industry puts forward perspectives to support the harmonization of regulatory requirements. These are intended to facilitate efficient regulatory review and approval to support timely implementation of changes and product improvements, leading to more resilient supply chains.

Read more
Statement 3 Dec 2023

Innovative pharmaceutical industry statement on COP28 Declaration on Climate and Health

On 3 December, innovative pharmaceutical trade associations issued a joint statement on the Declaration on Climate and Health at COP28.

Read more
Press release 1 Dec 2023

Biopharmaceutical CEO Roundtable meets in New York, focusing on global health and pharmaceutical innovation

The Biopharmaceutical CEO Roundtable (BCR), which represents the world’s leading biopharmaceutical companies, met in New York on 28 November 2023, to discuss global health challenges and public health policies impacting biomedical innovation. 1 December 2023, New York City – The CEOs of leading biopharmaceutical companies met to focus on global health challenges and the importance...

Read more
Press release 27 Nov 2023

Renewed partnership to boost the skills needed to drive drug discovery and development in Africa

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and H3D Foundation have today announced a new three-year phase of their partnership, aiming to boost the skills and capacity needed to drive increased research and development of new medicines in Africa.

Read more
Renewed partnership to boost the skills needed to drive drug discovery and development in Africa
Statement 22 Nov 2023

Joint statement on World Antimicrobial Awareness Week

To mark World Antimicrobial Awareness Week (WAAW) 2023, the International Alliance of Patients’ Organizations (IAPO), the IAPO Patients for Patient Safety Observatory and its AMR Patient Alliance, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the World Medical Association (WMA), the International Council of Nurses (ICN) and International Pharmaceutical Federation (FIP), call for cross-sectoral collaboration to address the growing threat of AMR.

Read more
External study 16 Nov 2023

The socio-economic value of adult immunization (OHE)(Poster)

This study by the Office of Health Economics (OHE) synthesizes existing evidence for the broad, socio-economic value of adult immunization programs, focusing on influenza, pneumococcal, herpes zoster (HZ), and respiratory syncytial virus (RSV) programs in ten countries (Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand, United States). In a forthcoming publication, OHE will...

Read more
Press release 6 Nov 2023

IFPMA announces leadership change in 2024

IFPMA’s Thomas Cueni to retire in April 2024, with Dr. David Reddy succeeding him as Director General

Read more
Statement 6 Nov 2023

IFPMA statement at the seventh meeting of the Intergovernmental Negotiating Body on Pandemic Accord

On 6 November in Geneva, IFPMA delivered a statement at the seventh meeting of the Intergovernmental Negotiating Body on the Pandemic Accord.

Read more
Statement 2 Nov 2023

IFPMA welcomes announcement of first three regulatory agencies listed under WHO Listed Authorities Framework

On 2 November, IFPMA and its member associations in South Korea, Singapore and Switzerland have welcomed the appointment of the Korean Ministry of Food and Drug Safety (MFDS) of South Korea, the Health Sciences Authority (HSA) of Singapore, and Swissmedic of Switzerland as the first three Listed Authorities under the WHO Listed Authorities (WLA) framework. 

Read more
Statement 2 Nov 2023

IFPMA statement on Universal Health Coverage at the 76th session of WHO Regional Committee for South-East Asia

On 2 November in New Delhi, India, IFPMA submitted a statement on Universal Health Coverage (UHC) at the 76th session of WHO Regional Committee for South-East Asia.

Read more
Statement 26 Oct 2023

IFPMA statement on health emergencies at the 73rd session of WHO Regional Committee for Europe

On 26 October in Astana, Kazakhstan, IFPMA submitted a statement on health emergency preparedness, response, and resilience in the WHO European Region (2024-2029): Preparing for a new regional strategy and action plan (Preparedness 2.0). In preparation for the new regional strategy on Health Emergency Preparedness 2.0, we would like to share some of industry’s key...

Read more
Statement 25 Oct 2023

IFPMA statement on health systems strengthening at the 73rd WHO Regional Committee for Europe

On 25 October in Astana, Kasakhstan, IFPMA submitted a statement on reaffirming commitment to health systems strengthening for universal health coverage, better outcomes, and reduced health inequalities.

Read more